Loprox (Medimetriks Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Loprox drug offered from Medimetriks Pharmaceuticals, Inc.. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Medimetriks Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | ciclopirox olamine |
| SUBSTANCE NAME: | CICLOPIROX OLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-01-14 |
| END MARKETING DATE: | 0000-00-00 |
Loprox HUMAN PRESCRIPTION DRUG Details:
| Item Description | Loprox from Medimetriks Pharmaceuticals, Inc. |
| LABELER NAME: | Medimetriks Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.7(mg/g) |
| START MARKETING DATE: | 2016-01-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43538-540_56413dd5-93d2-4953-919a-cabefce1b6ea |
| PRODUCT NDC: | 43538-540 |
| APPLICATION NUMBER: | NDA018748 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers:
